The finding of a significant correlation between PD-L1 expression levels in tumor tissue and responsiveness to PD-1 pathway blockade [10, 32] has led to the investigation of PD-L1 expression in a variety of cancers, with the goal of developing further applications of PD-1 pathway blockade [33-36]. This evidence concerns the gene CD274 and cancer.